ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HAO vs META // GROSS PROFIT MARGIN

Haoxi Health Technology Limited (Class A) (NASDAQ) VS. Meta Platforms, Inc. (NASDAQ) • 15-METRIC TALLY: HAO 2 — META 6
▲ GROSS PROFIT MARGIN LEADER: HAO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HAO VS. META) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HAO META SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 96.00% 81.03% +14.97 HAO /gross-margins <GO>
Return on Invested Capital (ROIC) — 18.19% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 16.3x — TIE /valuation <GO>
Free Cash Flow Yield — 1.82% — TIE /fcf-yield <GO>
Operating Margin -60.00% 32.86% -92.86 META /operating-margins <GO>
Net Profit Margin 68.00% 31.15% +36.85 HAO /net-margins <GO>
Revenue Growth (YoY) -54.60% 27.53% -82.13 META /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.34% -0.34 META /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 6.25 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 META /piotroski-score <GO>
Options Implied Move & Put/Call Skew — 8.11% — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.0 48.2 -14.20 META /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.39 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 22.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.3M $1.60T -$1.60T META /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HAO REV META REV HAO GROSS % META GROSS % HAO FCF META FCF
FY 2025 $537.6K $200.97B 98.0% 82.0% -$3.4M $46.11B
FY 2024 $1.2M $164.50B 98.0% 81.7% -$802.9K $54.07B
FY 2023 $28.2M $134.90B — 80.8% -$872.1K $44.07B
FY 2022 — $116.61B — 78.3% — $19.29B
FY 2021 — $117.93B — 80.8% — $38.99B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HAO // BETA —
META // BETA 1.39